We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Axos Financial
AX
$4.97B
| $18.1M | 0.37% |
561,852
-383,124
| -41% | -$11.4M |
2014 Q4
3 quarters
|
|
|
KSU
77
DELISTED
Kansas City Southern
KSU
| $17.6M | 0.36% |
193,944
-30,941
| -14% | -$2.92M |
2013 Q2
9 quarters
|
|
78
CF Industries
CF
$18.1B
| $16.8M | 0.34% |
373,514
-84,041
| -18% | -$4.89M |
2013 Q2
9 quarters
|
|
79
Visa
V
$750B
| $16.5M | 0.33% |
236,182
+18,860
| +9% | +$1.35M |
2013 Q2
9 quarters
|
|
80
Align Technology
ALGN
$10.6B
| $16.4M | 0.33% |
288,989
+22,465
| +8% | +$1.34M |
2013 Q2
9 quarters
|
|
81
Acuity Brands
AYI
$9.04B
| $16M | 0.32% |
91,332
-42,814
| -32% | -$8.32M |
2015 Q1
2 quarters
|
|
82
Alphabet (Google) Class A
GOOGL
$4.27T
| $15.8M | 0.32% |
+496,420
| New | +$16M |
2015 Q3
0 quarters
|
|
|
LNKD
83
DELISTED
LinkedIn Corporation
LNKD
| $15M | 0.3% |
78,759
+3,510
| +5% | +$697K |
2015 Q2
1 quarter
|
|
84
LyondellBasell Industries
LYB
$20.2B
| $14.7M | 0.3% |
176,913
-171,662
| -49% | -$15.3M |
2013 Q2
9 quarters
|
|
|
85
DELISTED
Stericycle Inc
SRCL
| $14.4M | 0.29% |
103,451
-210,174
| -67% | -$29.3M |
2013 Q2
9 quarters
|
|
86
FTAI Aviation
FTAI
$17.3B
| $13.2M | 0.27% |
1,203,197
+1,144,647
| +1,955% | +$14.8M |
2015 Q2
1 quarter
|
|
87
McKesson
MCK
$116B
| $13.1M | 0.26% |
70,856
+44,482
| +169% | +$9.43M |
2013 Q4
7 quarters
|
|
88
Berkshire Hathaway Class B
BRK.B
$1.13T
| $10.3M | 0.21% |
78,747
+7,990
| +11% | +$1.09M |
2013 Q2
9 quarters
|
|
89
Cboe Global Markets
CBOE
$32.2B
| $10.2M | 0.21% |
152,605
-25,781
| -14% | -$1.63M |
2013 Q2
9 quarters
|
|
90
Walt Disney
DIS
$191B
| $10.2M | 0.21% |
100,146
-21,021
| -17% | -$2.29M |
2013 Q2
9 quarters
|
|
91
Moody's
MCO
$83.8B
| $9.79M | 0.2% |
99,742
+5,245
| +6% | +$558K |
2014 Q1
6 quarters
|
|
92
Booking.com
BKNG
$125B
| $9.53M | 0.19% |
192,600
+18,625
| +11% | +$925K |
2013 Q3
8 quarters
|
|
93
Plains All American Pipeline
PAA
$17.7B
| $8.83M | 0.18% |
290,683
-38,747
| -12% | -$1.42M |
2013 Q2
9 quarters
|
|
94
iShares Core S&P Small-Cap ETF
IJR
$103B
| $8.73M | 0.18% |
163,778
+5,270
| +3% | +$299K |
2013 Q2
9 quarters
|
|
95
Danaher
DHR
$163B
| $8.67M | 0.17% |
151,376
+3,451
| +2% | +$204K |
2013 Q2
9 quarters
|
|
96
Johnson & Johnson
JNJ
$610B
| $8.36M | 0.17% |
89,570
+616
| +0.7% | +$59.6K |
2013 Q2
9 quarters
|
|
|
97
Biogen
BIIB
$34.8B
| $8.28M | 0.17% |
28,362
-150,959
| -84% | -$49.9M |
2013 Q2
9 quarters
|
|
|
ETP
98
DELISTED
Energy Transfer Partners, L.P.
ETP
| $8.2M | 0.17% |
286,133
-533,793
| -65% | -$18.1M |
2013 Q2
9 quarters
|
|
99
HDFC Bank
HDB
$121B
| $8.18M | 0.17% |
535,684
-169,020
| -24% | -$2.55M |
2013 Q2
9 quarters
|
|
100
iShares Russell 2000 ETF
IWM
$77.5B
| $8.13M | 0.16% |
74,467
+6,304
| +9% | +$747K |
2013 Q2
9 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.